These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 31752352

  • 21. Strong CD4 T Cell Responses to Zika Virus Antigens in a Cohort of Dengue Virus Immune Mothers of Congenital Zika Virus Syndrome Infants.
    Reynolds CJ, Watber P, Santos CNO, Ribeiro DR, Alves JC, Fonseca ABL, Bispo AJB, Porto RLS, Bokea K, de Jesus AMR, de Almeida RP, Boyton RJ, Altmann DM.
    Front Immunol; 2020; 11():185. PubMed ID: 32132999
    [Abstract] [Full Text] [Related]

  • 22. Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination.
    Nivarthi UK, Kose N, Sapparapu G, Widman D, Gallichotte E, Pfaff JM, Doranz BJ, Weiskopf D, Sette A, Durbin AP, Whitehead SS, Baric R, Crowe JE, de Silva AM.
    J Virol; 2017 Mar 01; 91(5):. PubMed ID: 28031369
    [Abstract] [Full Text] [Related]

  • 23. Protective and enhancing interactions among dengue viruses 1-4 and Zika virus.
    Katzelnick LC, Bos S, Harris E.
    Curr Opin Virol; 2020 Aug 01; 43():59-70. PubMed ID: 32979816
    [Abstract] [Full Text] [Related]

  • 24. Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection.
    Weiskopf D, Angelo MA, Sidney J, Peters B, Shresta S, Sette A.
    J Virol; 2014 Oct 01; 88(19):11383-94. PubMed ID: 25056881
    [Abstract] [Full Text] [Related]

  • 25. Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes.
    Andrade DV, Katzelnick LC, Widman DG, Balmaseda A, de Silva AM, Baric RS, Harris E.
    mBio; 2017 Sep 19; 8(5):. PubMed ID: 28928210
    [Abstract] [Full Text] [Related]

  • 26. Seroprevalence of Zika and Dengue Virus Antibodies among Migrant Workers, Taiwan, 2017.
    Perng GC, Ho TC, Shih HI, Lee CH, Huang PW, Chung CH, Ko NY, Ko WC, Chien YW.
    Emerg Infect Dis; 2019 Apr 19; 25(4):814-816. PubMed ID: 30882327
    [Abstract] [Full Text] [Related]

  • 27. Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development.
    Roth C, Delgado FG, Simon-Lorière E, Sakuntabhai A.
    Int J Environ Res Public Health; 2018 Feb 23; 15(2):. PubMed ID: 29473899
    [Abstract] [Full Text] [Related]

  • 28. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
    Fowler AM, Tang WW, Young MP, Mamidi A, Viramontes KM, McCauley MD, Carlin AF, Schooley RT, Swanstrom J, Baric RS, Govero J, Diamond MS, Shresta S.
    Cell Host Microbe; 2018 Nov 14; 24(5):743-750.e5. PubMed ID: 30439343
    [Abstract] [Full Text] [Related]

  • 29. DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection.
    Slon Campos JL, Poggianella M, Marchese S, Mossenta M, Rana J, Arnoldi F, Bestagno M, Burrone OR.
    PLoS One; 2017 Nov 14; 12(7):e0181734. PubMed ID: 28742857
    [Abstract] [Full Text] [Related]

  • 30. Computational Analysis of Dengue Virus Envelope Protein (E) Reveals an Epitope with Flavivirus Immunodiagnostic Potential in Peptide Microarrays.
    Bergamaschi G, Fassi EMA, Romanato A, D'Annessa I, Odinolfi MT, Brambilla D, Damin F, Chiari M, Gori A, Colombo G, Cretich M.
    Int J Mol Sci; 2019 Apr 18; 20(8):. PubMed ID: 31003530
    [Abstract] [Full Text] [Related]

  • 31. Zika convalescent macaques display delayed induction of anamnestic cross-neutralizing antibody responses after dengue infection.
    Valiant WG, Huang YS, Vanlandingham DL, Higgs S, Lewis MG, Mattapallil JJ.
    Emerg Microbes Infect; 2018 Jul 13; 7(1):130. PubMed ID: 30006514
    [Abstract] [Full Text] [Related]

  • 32. The human antibody response to dengue virus infection.
    Wahala WM, Silva AM.
    Viruses; 2011 Dec 13; 3(12):2374-95. PubMed ID: 22355444
    [Abstract] [Full Text] [Related]

  • 33. Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans.
    Delgado FG, Torres KI, Castellanos JE, Romero-Sánchez C, Simon-Lorière E, Sakuntabhai A, Roth C.
    Viruses; 2018 Sep 07; 10(9):. PubMed ID: 30205518
    [Abstract] [Full Text] [Related]

  • 34. Linear epitope mapping in the E and NS1 proteins of dengue and Zika viruses: Prospection of peptides for vaccines and diagnostics.
    Aquino VH, Fumagalli MJ, Silva A, de Moura Negrini BV, Rojas A, Guillen Y, Bernal C, Figueiredo LTM.
    PLoS One; 2023 Sep 07; 18(10):e0292451. PubMed ID: 37788262
    [Abstract] [Full Text] [Related]

  • 35. Zika Virus-Induced Antibody Response Enhances Dengue Virus Serotype 2 Replication In Vitro.
    Kawiecki AB, Christofferson RC.
    J Infect Dis; 2016 Nov 01; 214(9):1357-1360. PubMed ID: 27521359
    [Abstract] [Full Text] [Related]

  • 36. Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions.
    de Alwis R, Smith SA, Olivarez NP, Messer WB, Huynh JP, Wahala WM, White LJ, Diamond MS, Baric RS, Crowe JE, de Silva AM.
    Proc Natl Acad Sci U S A; 2012 May 08; 109(19):7439-44. PubMed ID: 22499787
    [Abstract] [Full Text] [Related]

  • 37. [Mapping of the B Cell Neutralizing Epitopes on ED III of Envelope Protein from Dengue Virus].
    Lin Y, Wen K, Guo Y, Qiu L, Pan Y, Yu L, Di B, Chen Y.
    Bing Du Xue Bao; 2015 Nov 08; 31(6):665-73. PubMed ID: 26951013
    [Abstract] [Full Text] [Related]

  • 38. Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope.
    Metz SW, Thomas A, White L, Stoops M, Corten M, Hannemann H, de Silva AM.
    Virol J; 2018 Apr 02; 15(1):60. PubMed ID: 29609659
    [Abstract] [Full Text] [Related]

  • 39. Detection of Dengue Virus-Specific IgM and IgG Antibodies through Peptide Sequences of Envelope and NS1 Proteins for Serological Identification.
    Nagar PK, Savargaonkar D, Anvikar AR.
    J Immunol Res; 2020 Apr 02; 2020():1820325. PubMed ID: 32832567
    [Abstract] [Full Text] [Related]

  • 40. Identification of Immunodominant Epitopes of Dengue Virus 2 Envelope and NS1 Proteins: Evaluating the Diagnostic Potential of a Synthetic Peptide.
    Singha S, Nath N, Sarma V, Barman K, Sharma GC, Saikia L, Baruah S.
    Mol Diagn Ther; 2024 Sep 02; 28(5):633-643. PubMed ID: 38980575
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.